Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study
Language English Country United States Media print
Document type Journal Article, Multicenter Study
Grant support
Austrian Ministry of Health
Czechia Ministry of Health
PI18CIII-00035
Foundation for Influenza Epidemiology
Santé Publique France
PE00000007
European Union
Ministry of Health
Welfare and Sport, The Netherlands
National Health Insurance
National Surveillance Program
P3-0083
Slovenian Research Agency
UK Clinical Virology Network
31CA30_196046
Swiss National Science Foundation - Switzerland
University of Bern
PubMed
38547499
PubMed Central
PMC11481312
DOI
10.1093/infdis/jiae154
PII: 7637136
Knihovny.cz E-resources
- Keywords
- European Non-Polio Enterovirus Network (ENPEN), acute flaccid myelitis (AFM), enterovirus D68 (EV-D68), nonpolio enterovirus (NPEV), respiratory infection,
- MeSH
- Child MeSH
- Adult MeSH
- Enterovirus Infections * epidemiology virology MeSH
- Phylogeny * MeSH
- Respiratory Tract Infections virology epidemiology MeSH
- Infant MeSH
- Middle Aged MeSH
- Humans MeSH
- Enterovirus D, Human * genetics classification isolation & purification MeSH
- Adolescent MeSH
- Young Adult MeSH
- Myelitis epidemiology virology MeSH
- Neuromuscular Diseases epidemiology virology MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Aged MeSH
- Central Nervous System Viral Diseases epidemiology virology MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Geographicals
- Europe epidemiology MeSH
Enterovirus D68 (EV-D68) infections are associated with severe respiratory disease and acute flaccid myelitis (AFM). The European Non-Polio Enterovirus Network (ENPEN) aimed to investigate the epidemiological and genetic characteristics of EV-D68 infections and its clinical impact during the fall-winter season of 2021-2022. From 19 European countries, 58 institutes reported 10 481 (6.8%) EV-positive samples of which 1004 (9.6%) were identified as EV-D68 (including 852 respiratory samples). Clinical data were reported for 969 cases; 78.9% of infections were reported in children (0-5 years); and 37.9% of cases were hospitalized. Acute respiratory distress was commonly noted (93.1%) followed by fever (49.4%). Neurological problems were observed in 6.4% of cases including 6 diagnosed with AFM. Phylodynamic/Nextstrain and phylogenetic analyses based on 694 sequences showed the emergence of 2 novel B3-derived lineages, with no regional clustering. In conclusion, we describe a large-scale European EV-D68 upsurge with severe clinical impact and the emergence of B3-derived lineages.
Clinic of Infectious Diseases University Hospital Prof Dr Stoyan Kirkovich AD Stara Zagora Bulgaria
Clinical and Epidemiological Virology Rega Institute Katholieke Universiteit Leuven Leuven Belgium
Commission for Polio Eradication in Germany Robert Koch Institute Berlin Germany
Department of Biomedical Sciences for Health University of Milan Milan Italy
Department of Clinical Microbiology Karolinska University Hospital Stockholm Sweden
Department of Clinical Research Nordsjællands Hospital Hilleroed Denmark
Department of Medical Microbiology and Immunology Meander Medical Center Amersfoort The Netherlands
Department of Medical Microbiology Maasstad Hospital Rotterdam The Netherlands
Department of Medical Microbiology Reinier Haga Medical Diagnostic Center Delft The Netherlands
Department of Medical Microbiology St Jansdal Hospital Harderwijk The Netherlands
Department of Medical Microbiology St Olavs Hospital Trondheim University Hospital Trondheim Norway
Department of Microbiology Oslo University Hospital Oslo Norway
Department of Microbiology Public Health Agency of Sweden Solna Sweden
Department of Microbiology Tumor and Cell Biology Karolinska Institutet Stockholm Sweden
Department of Public Health University of Copenhagen Copenhagen Denmark
Department of Virology Croatian Institute of Public Health Zagreb Croatia
Department of Virology Norwegian Institute of Public Health Oslo Norway
Department of Viroscience Erasmus Medical Center Rotterdam The Netherlands
Enteric Virus Unit UK Health Security Agency London United Kingdom
European Non Polio Enterovirus Network
GFO Kliniken Bonn Betriebsstätte St Marien Bonn Germany
Insititute of Clinical Medicine University of Oslo Oslo Norway
Insitute of Virology Medical Faculty University Bonn Bonn Germany
Institute of Medical Microbiology and Virology University of Leipzig Leipzig Germany
Institute of Social and Preventive Medicine University of Bern Bern Switzerland
Laboratoire de Virologie ULR Univ Lille Centre Hospitalier Universitaire de Lille Lille France
Laboratory for Medical Microbiology and Immunology Rijnstate Velp The Netherlands
Laboratory for Medical Microbiology and Public Health Hengelo The Netherlands
Laboratory for Medical Microbiology Eurofins PAMM Veldhoven The Netherlands
Laboratory Medical Microbiology and Immunology Admiraal de Ruijter Hospital Goes The Netherlands
Laboratory Medicine Molecular Microbiology AZ St Jan Brugge Oostende AV Bruges Belgium
Microbiology Department Complejo Hospitalario de Navarra Navarra Spain
National Health Service Blood and Transplant Microbiology Services Colindale United Kingdom
National Public Health Center Budapest Hungary
National Virus Reference Laboratory University College Dublin Dublin Ireland
Nuffield Department for Medicine University of Oxford Oxford United Kingdom
Pediatric Infectious Diseases Unit Hospital Universitario Virgen de la Arrixaca Murcia Spain
Service de Biologie Centre Hospitalier de Versailles Le Chesnay France
Swiss Institute of Bioinformatics Lausanne Switzerland
Virology Department Centre Hospitalier Universitaire Hôtel Dieu University Hospital Nantes France
Virology Department University Hospital of Bordeaux Bordeaux France
See more in PubMed
Hixon AM, Frost J, Rudy MJ, Messacar K, Clarke P, Tyler KL. Understanding enterovirus D68-induced neurologic disease: a basic science review. Viruses 2019; 11:821. PubMed PMC
Sooksawasdi Na Ayudhya S, Laksono BM, van Riel D. The pathogenesis and virulence of enterovirus-D68 infection. Virulence 2021; 12:2060–72. PubMed PMC
Elrick MJ, Pekosz A, Duggal P. Enterovirus D68 molecular and cellular biology and pathogenesis. J Biol Chem 2021; 296:100317. PubMed PMC
Zhang W, Luan R. Estimating the impact of non-pharmaceutical interventions against COVID-19 on mumps incidence in Sichuan, China. BMC Infect Dis 2021; 21:886. PubMed PMC
Larsson SB, Vracar D, Karlsson M, Ringlander J, Norder H. Epidemiology and clinical manifestations of different enterovirus and rhinovirus types show that EV-D68 may still have an impact on severity of respiratory infections. J Med Virol 2022; 94:3829–39. PubMed PMC
Zell R, Delwart E, Gorbalenya AE, et al. . ICTV virus taxonomy profile: Picornaviridae. J Gen Virol 2017; 98:2421–2. PubMed PMC
Harvala H, Broberg E, Benschop K, et al. . Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol 2018; 101:11–7. PubMed
Andres C, Vila J, Creus-Costa A, et al. . Enterovirus D68 in hospitalized children, Barcelona, Spain, 2014–2021. Emerg Infect Dis 2022; 28:1327–31. PubMed PMC
Meijer A, van der Sanden S, Snijders BE, et al. . Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology 2012; 423:49–57. PubMed
Piralla A, Lilleri D, Sarasini A, et al. . Human rhinovirus and human respiratory enterovirus (EV68 and EV104) infections in hospitalized patients in Italy, 2008–2009. Diagn Microbiol Infect Dis 2012; 73:162–7. PubMed
Poelman R, Schuffenecker I, Van Leer-Buter C, et al. . European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014. J Clin Virol 2015; 71:1–9. PubMed
Fischer TK, Simmonds P, Harvala H. The importance of enterovirus surveillance in a post-polio world. Lancet Infect Dis 2022; 22:e35–40. PubMed
Kramer R, Sabatier M, Wirth T, et al. . Molecular diversity and biennial circulation of enterovirus D68: a systematic screening study in Lyon, France, 2010 to 2016. Euro Surveill 2018; 23:1700711. PubMed PMC
Cottrell S, Moore C, Perry M, Hilvers E, Williams C, Shankar AG. Prospective enterovirus D68 (EV-D68) surveillance from September 2015 to November 2018 indicates a current wave of activity in Wales. Euro Surveill 2018; 23:1800578. PubMed PMC
Hodcroft EB, Dyrdak R, Andres C, et al. . Evolution, geographic spreading, and demographic distribution of enterovirus D68. PLoS Pathog 2022; 18:e1010515. PubMed PMC
Holm-Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: a systematic review. Lancet Infect Dis 2016; 16:e64–75. PubMed
Xiang Z, Wang J. Enterovirus D68 and human respiratory infections. Semin Respir Crit Care Med 2016; 37:578–85. PubMed PMC
Messacar K, Tyler KL. Enterovirus D68-associated acute flaccid myelitis: rising to the clinical and research challenges. JAMA 2019; 321:831–2. PubMed PMC
Helfferich J, de Lange MM, Benschop KS, et al. . Epidemiology of acute flaccid myelitis in children in The Netherlands, 2014 to 2019. Euro Surveill 2022; 27:2200157. PubMed PMC
Lang M, Mirand A, Savy N, et al. . Acute flaccid paralysis following enterovirus D68 associated pneumonia, France, 2014. Euro Surveill 2014; 19:20952. PubMed
Pfeiffer HC, Bragstad K, Skram MK, et al. . Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014. Euro Surveill 2015; 20:21062. PubMed
Midgley SE, Benschop K, Dyrdak R, et al. . Co-circulation of multiple enterovirus D68 subclades, including a novel B3 cluster, across Europe in a season of expected low prevalence, 2019/20. Euro Surveill 2020; 25:1900749. PubMed PMC
Benschop KS, Albert J, Anton A, et al. . Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021. Euro Surveill 2021; 26:2100998. PubMed PMC
Benschop KSM, Broberg EK, Hodcroft E, et al. . Molecular epidemiology and evolutionary trajectory of emerging echovirus 30, Europe. Emerg Infect Dis 2021; 27:1616–26. PubMed PMC
Huddleston J, Hadfield J, Sibley TR, et al. . Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens. J Open Source Softw 2021; 6:2906. PubMed PMC
Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016; 33:1870–4. PubMed PMC
Simmonds P. SSE: a nucleotide and amino acid sequence analysis platform. BMC Res Notes 2012; 5:50. PubMed PMC
Tedcastle A, Wilton T, Pegg E, et al. . Detection of enterovirus D68 in wastewater samples from the UK between July and November 2021. Viruses 2022; 14:143. PubMed PMC
Park SW, Pons-Salort M, Messacar K, et al. . Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med 2021; 13:eabd2400. PubMed
van Summeren J, Meijer A, Aspelund G, et al. . Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill 2021; 26:2100639. PubMed PMC
Wang LP, Han JY, Zhou SX, et al. . The changing pattern of enteric pathogen infections in China during the COVID-19 pandemic: a nation-wide observational study. Lancet Reg Health West Pac 2021; 16:100268. PubMed PMC
Liu P, Xu M, Lu L, et al. . The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: two years of the COVID-19 pandemic. J Med Virol 2022; 94:4696–703. PubMed PMC
Olsen SJ, Winn AK, Budd AP, et al. . Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020–2021. Am J Transplant 2021; 21:3481–6. PubMed PMC
Honemann M, Thiem S, Bergs S, et al. . In-depth analysis of the re-emergence of respiratory syncytial virus at a tertiary care hospital in Germany in the summer of 2021 after the alleviation of non-pharmaceutical interventions due to the SARS-CoV-2 pandemic. Viruses 2023; 15:877. PubMed PMC
Cassidy H, Poelman R, Knoester M, Van Leer-Buter CC, Niesters HGM. Enterovirus D68—the new polio? Front Microbiol 2018; 9:2677. PubMed PMC
Penela-Sanchez D, Gonzalez-de-Audicana J, Armero G, et al. . Lower respiratory tract infection and genus enterovirus in children requiring intensive care: clinical manifestations and impact of viral co-infections. Viruses 2021; 13:2059. PubMed PMC
Freeman MC, Wells AI, Ciomperlik-Patton J, et al. . Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates. Elife 2021; 10:e66687. PubMed PMC
Giardina FAM, Piralla A, Ferrari G, Zavaglio F, Cassaniti I, Baldanti F. Molecular epidemiology of rhinovirus/enterovirus and their role on cause severe and prolonged infection in hospitalized patients. Microorganisms 2022; 10:755. PubMed PMC
Sinclair W, Omar M. Enterovirus. StatPearls. Treasure Island, FL: StatPearls Publishing, 2022. PubMed
Christy A, Messacar K. Acute flaccid myelitis associated with enterovirus D68: a review. J Child Neurol 2019; 34:511–6. PubMed
Knoester M, Helfferich J, Poelman R, et al. . Twenty-nine cases of enterovirus-D68-associated acute flaccid myelitis in Europe 2016: a case series and epidemiologic overview. Pediatr Infect Dis J 2019; 38:16–21. PubMed PMC
Helfferich J, Knoester M, Van Leer-Buter CC, et al. . Acute flaccid myelitis and enterovirus D68: lessons from the past and present. Eur J Pediatr 2019; 178:1305–15. PubMed PMC
Murphy OC, Messacar K, Benson L, et al. . Acute flaccid myelitis: cause, diagnosis, and management. Lancet 2021; 397:334–46. PubMed PMC
Rha B, Curns AT, Lively JY, et al. . Respiratory syncytial virus-associated hospitalizations among young children: 2015–2016. Pediatrics 2020; 146:e20193611. PubMed
Chen Z, Schiffman M, Herrero R, et al. . Classification and evolution of human papillomavirus genome variants: alpha-5 (HPV26, 51, 69, 82), alpha-6 (HPV30, 53, 56, 66), alpha-11 (HPV34, 73), alpha-13 (HPV54) and alpha-3 (HPV61). Virology 2018; 516:86–101. PubMed PMC
Graf T, Bello G, Venas TMM, et al. . Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern. Virus Evol 2021; 7:veab091. PubMed PMC
Huang C, Yu J, Hause BM, et al. . Emergence of new phylogenetic lineage of influenza D virus with broad antigenicity in California, United States. Emerg Microbes Infect 2021; 10:739–42. PubMed PMC
Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006; 44:2698–704. PubMed PMC